This month’s Fifth Annual Review issue of The Oncology Nurse-APN/PA® (TON) highlights some of the recent advances in anticancer care. We focus on some of the therapies that received approval from the US Food and Drug Administration (FDA) in 2012.
This month’s issue demonstrates how rapidly practices are changing and how important it is for oncology nurses to be aware of those advances in care already affecting patients or likely to affect them in the near future. Informed nurses can help educate patients about the newer treatments—from having realistic expectations about the therapy and its side effects to providing information about financial assistance programs to help pay for the drug regimen.
We would like to thank all of the authors who contributed to this issue of TON. Some were directly involved with the clinical studies that were evaluated during the FDA approval process while others are experts in the therapeutic area discussed. All authors have a deep understanding of the subject area and share a passion for improving care for patients with cancer.